These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31596484)

  • 41. Survival and spirometry outcomes after lung transplantation from donors aged 70 years and older.
    Sommer W; Ius F; Salman J; Avsar M; Tudorache I; Kühn C; Wiegmann B; Marsch G; Kaufeld T; Zinne N; Fuehner T; Greer M; Gottlieb J; Boethig D; Haverich A; Welte T; Warnecke G
    J Heart Lung Transplant; 2015 Oct; 34(10):1325-33. PubMed ID: 26186805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early pulmonary function and mid-term outcome in lung transplantation after ex-vivo lung perfusion - a single-center, retrospective, observational, cohort study.
    Fumagalli J; Rosso L; Gori F; Morlacchi LC; Rossetti V; Tarsia P; Blasi F; Righi I; Mendogni P; Palleschi A; Tosi D; Bonitta G; Nosotti M; Benazzi E; Scaravilli V; Valenza F; Grasselli G; Zanella A
    Transpl Int; 2020 Jul; 33(7):773-785. PubMed ID: 32219887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-year experience with ex vivo lung perfusion: Preliminary results from a single center.
    Koch A; Pizanis N; Olbertz C; Abou-Issa O; Taube C; Slama A; Aigner C; Jakob HG; Kamler M
    Int J Artif Organs; 2018 Aug; 41(8):460-466. PubMed ID: 29976122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.
    Van Raemdonck D; Keshavjee S; Levvey B; Cherikh WS; Snell G; Erasmus M; Simon A; Glanville AR; Clark S; D'Ovidio F; Catarino P; McCurry K; Hertz MI; Venkateswaran R; Hopkins P; Inci I; Walia R; Kreisel D; Mascaro J; Dilling DF; Camp P; Mason D; Musk M; Burch M; Fisher A; Yusen RD; Stehlik J; Cypel M;
    J Heart Lung Transplant; 2019 Dec; 38(12):1235-1245. PubMed ID: 31777330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular Ex Vivo Lung Perfusion Beyond 1 Hour May Improve Marginal Donor Lung Assessment.
    Niikawa H; Okamoto T; Ayyat KS; Itoda Y; Sakanoue I; Farver CF; Yun JJ; McCurry KR
    J Surg Res; 2020 Jun; 250():88-96. PubMed ID: 32028151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Retrospective Review of Declined Lung Donors: Estimating the Potential of Ex Vivo Lung Perfusion.
    Okahara S; Levvey B; McDonald M; D'Costa R; Opdam H; Pilcher DV; Snell GI
    Ann Thorac Surg; 2021 Aug; 112(2):443-449. PubMed ID: 33121967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.
    Charles EJ; Huerter ME; Wagner CE; Sharma AK; Zhao Y; Stoler MH; Mehaffey JH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
    Ann Thorac Surg; 2016 Dec; 102(6):1845-1853. PubMed ID: 27614736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ex vivo lung perfusion in Brazil.
    Abdalla LG; Braga KA; Nepomuceno NA; Fernandes LM; Samano MN; Pêgo-Fernandes PM
    J Bras Pneumol; 2016 Apr; 42(2):95-8. PubMed ID: 27167429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of donor lung weight at procurement and during ex vivo lung perfusion.
    Okamoto T; Ayyat KS; Sakanoue I; Niikawa H; Said SA; Ahmad U; Unai S; Bribriesco A; Elgharably H; Budev MM; Yun JJ; McCurry KR
    J Heart Lung Transplant; 2022 Jun; 41(6):818-828. PubMed ID: 35307267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation.
    Valenza F; Rosso L; Gatti S; Coppola S; Froio S; Colombo J; Dossi R; Pizzocri M; Salice V; Nosotti M; Reggiani P; Tosi D; Palleschi A; Pappalettera M; Ferrero S; Perazzoli A; Costantini D; Scalamogna M; Rossi G; Colombo C; Santambrogio L; Gattinoni L
    Transplant Proc; 2012 Sep; 44(7):1826-9. PubMed ID: 22974847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion.
    Nakajima D; Chen F; Yamada T; Sakamoto J; Ohsumi A; Bando T; Date H
    J Heart Lung Transplant; 2012 Feb; 31(2):187-93. PubMed ID: 22305381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute kidney injury after ex vivo lung perfusion (EVLP).
    Hauck J; Osho A; Castleberry A; Hartwig M; Reddy L; Phillips-Bute B; Swaminathan M; Mathew J; Stafford-Smith M
    Transplant Proc; 2014 Dec; 46(10):3598-602. PubMed ID: 25498096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ex-vivo lung perfusion.
    Moreno Garijo J; Roscoe A
    Curr Opin Anaesthesiol; 2020 Feb; 33(1):50-54. PubMed ID: 31688085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.
    Ricardo-da-Silva FY; Armstrong-Jr R; Ramos MMA; Vidal-Dos-Santos M; Jesus Correia C; Ottens PJ; Moreira LFP; Leuvenink HGD; Breithaupt-Faloppa AC
    Biol Sex Differ; 2024 Jan; 15(1):11. PubMed ID: 38287395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significant parameters in the evaluation of donor lungs in single-lung cellular ex vivo lung perfusion.
    Niikawa H; Okamoto T; Ayyat KS; Itoda Y; Hata JS; McCurry KR
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):767-774. PubMed ID: 30535021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.
    Inci I; Arni S; Iskender I; Citak N; Rodriguez JM; Weisskopf M; Opitz I; Weder W; Frauenfelder T; Krafft MP; Spahn DR
    Cells; 2020 Nov; 9(11):. PubMed ID: 33218154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm.
    Sommer W; Kühn C; Tudorache I; Avsar M; Gottlieb J; Boethig D; Haverich A; Warnecke G
    J Heart Lung Transplant; 2013 Nov; 32(11):1065-72. PubMed ID: 23953918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.
    Beller JP; Byler MR; Money DT; Chancellor WZ; Zhang A; Zhao Y; Stoler MH; Narahari AK; Shannon A; Mehaffey JH; Tribble CG; Laubach VE; Kron IL; Roeser ME
    J Heart Lung Transplant; 2020 Jan; 39(1):74-82. PubMed ID: 31761511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants.
    Shin J; Hsin MK; Baciu C; Chen Y; Zamel R; Machuca T; Yeung J; Cypel M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2021 Jun; 40(6):525-535. PubMed ID: 33849769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience with the first 50 ex vivo lung perfusions in clinical transplantation.
    Cypel M; Yeung JC; Machuca T; Chen M; Singer LG; Yasufuku K; de Perrot M; Pierre A; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1200-6. PubMed ID: 22944089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.